This study aims to demonstrate the value of the care currently provided to patients with early and localised prostate cancer in our clinic over their full cycle of care. Current curative radiation treatments include: External Beam Radiotherapy (EBRT), brachytherapy (BT, permanent or temporary seed implantation) Hormonal Therapy, and combinations of all of these options. Meaningful patient information will be collected on the participating patients to include their background status, treatments, and their self-reported results of the treatment also referred to as,” Outcomes”. These may be as reported by the patients themselves, also known as “Patient–Reported Outcome Measurement” or “PROMS“ for short; as well as outcomes reported by the healthcare professionals involved (doctors, nurses etc). Using these PROM measures, we will be able to determine patients’ preferences for the various types of prostate cancer treatment (active surveillance, brachytherapy, EBRT, surgery). To do this we will use Discrete Choice Experiment (DCE) methodology. A DCE revolves around identifying attributes/characteristics of, in our case, prostate cancer treatments and how different levels of these attributes might affect patient’s preferences for a particular treatment.
